Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.12)
# 3,487
Out of 4,829 analysts
370
Total ratings
25.75%
Success rate
-13.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Reiterates: Buy | $40 | $10.38 | +285.36% | 15 | May 9, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $12.79 | +447.30% | 14 | Apr 21, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $3.17 | +846.37% | 10 | Apr 8, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $70 | $34.06 | +105.55% | 6 | Apr 8, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $10 | $2.22 | +350.45% | 1 | Apr 7, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.70 | +1,328.16% | 25 | Apr 7, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $17.41 | +359.51% | 8 | Apr 7, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.59 | +114.67% | 17 | Apr 3, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $500 | $251.15 | +99.08% | 26 | Apr 2, 2025 | |
| MIST Milestone Pharmaceuticals | Maintains: Buy | $25 → $10 | $1.11 | +800.90% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.13 | +1,069.59% | 17 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.65 | +1,447.75% | 17 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.39 | +619.42% | 18 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.11 | +800.90% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $28.40 | +252.11% | 20 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.52 | +863.02% | 17 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $6.15 | +794.31% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $3.70 | +1,927.03% | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $3.79 | +1,087.34% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.09 | +2,063.23% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $32.49 | +161.62% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.05 | +2,027.66% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $13.03 | +513.97% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.63 | +398.90% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $0.33 | +5,997.56% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $278.24 | +22.20% | 1 | Aug 18, 2021 |
GH Research
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $10.38
Upside: +285.36%
uniQure
Apr 21, 2025
Reiterates: Buy
Price Target: $70
Current: $12.79
Upside: +447.30%
Voyager Therapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.17
Upside: +846.37%
Harmony Biosciences Holdings
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $34.06
Upside: +105.55%
Alto Neuroscience
Apr 7, 2025
Initiates: Buy
Price Target: $10
Current: $2.22
Upside: +350.45%
Sangamo Therapeutics
Apr 7, 2025
Reiterates: Buy
Price Target: $10
Current: $0.70
Upside: +1,328.16%
Beam Therapeutics
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $17.41
Upside: +359.51%
Altimmune
Apr 3, 2025
Reiterates: Buy
Price Target: $12
Current: $5.59
Upside: +114.67%
Alnylam Pharmaceuticals
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $251.15
Upside: +99.08%
Milestone Pharmaceuticals
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.11
Upside: +800.90%
Mar 28, 2025
Reiterates: Buy
Price Target: $60
Current: $5.13
Upside: +1,069.59%
Mar 26, 2025
Reiterates: Buy
Price Target: $10
Current: $0.65
Upside: +1,447.75%
Mar 19, 2025
Reiterates: Buy
Price Target: $10
Current: $1.39
Upside: +619.42%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.11
Upside: +800.90%
Mar 12, 2025
Reiterates: Buy
Price Target: $100
Current: $28.40
Upside: +252.11%
Mar 10, 2025
Reiterates: Buy
Price Target: $5
Current: $0.52
Upside: +863.02%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $6.15
Upside: +794.31%
Mar 7, 2025
Reiterates: Buy
Price Target: $75
Current: $3.70
Upside: +1,927.03%
Mar 4, 2025
Reiterates: Buy
Price Target: $45
Current: $3.79
Upside: +1,087.34%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.09
Upside: +2,063.23%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $32.49
Upside: +161.62%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.05
Upside: +2,027.66%
Feb 12, 2025
Reiterates: Buy
Price Target: $80
Current: $13.03
Upside: +513.97%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.63
Upside: +398.90%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.33
Upside: +5,997.56%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $278.24
Upside: +22.20%